GLA and cancer: The escape of EVs from endosomes is useful for delivering endocytosed proteins to the cytoplasm, hence modifying cancer-cell-derived EVs with GALA peptide, a 30-amino-acid synthetic peptide with a glutamic acid–alanine–leucine–alanine (EALA) repeat, exerts a membrane-disrupting ability in a low-pH environment.